SIMCERE PHARMACEUTICAL GROUP Finite-Lived Intangible Asset, Expected Amortization, Year Five
SIMCERE PHARMACEUTICAL GROUP had Finite-Lived Intangible Asset, Expected Amortization, Year Five of CNY 22.07 million as of 2012-12-31, per its 20-F filed 2013-04-26.
Discontinued › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive · last filed 2013-04-26
- 2012-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Five 22.07M CNY.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year Five |
|---|---|
| 2012-12-31 | 22.07M CNY 20-F · filed 2013-04-26 |